10.1111/tpj.15912 53 ItohK.NakamuraK.IijimaM.SesakiH
Because our programs are supervised by medical professionals, we monitor your progress and health closely to ensure the treatment is both safe and effective for you
ESSENCE: A phase 3 efficacy and safety trial of Wegovy injection in patients with MASH with liver fibrosis 1,2 ESSENCE : A 2-part, 240-week, double-blind, placebo-controlled, phase 3 trial that randomized 1,197 adults with noncirrhotic MASH with fibrosis stage 2 or 3 and NAS 4 (1 in steatosis, lobular inflammation, and hepatocyte ballooning)
Theyre ideal when quick, reliable results are needed
This often lands at 40-60% of your peak dose
Under exercise or stress conditions, the demand for carnitine increases